Percutaneous Coronary Intervention

An analysis of the team approach to decision-making for multivessel CAD indicated that the consensus of a heart team was discordant with patients’ original treating interventionalist in nearly one-third of cases, researchers reported.

In a cross-sectional study of patients with acute MI, there were more observed fatalities than expected during the early period of the COVID-19 pandemic.

Healio and Cardiology Today have compiled a list of the most-read articles of July 2020.

Cardiac CT may be the ideal imaging technique during the COVID-19 pandemic compared with transesophageal echocardiography, according to a presentation at the Society of Cardiovascular Computed Tomography Annual Scientific Meeting.

A reduced dose of prasugrel in patients with ACS maintained its anti-ischemic effect without elevated bleeding risk compared with patients treated with a standard dose of ticagrelor, regardless of age or weight, researchers found.

In a meta-analysis of trials of patients with STEMI and multivessel CAD who underwent PCI, those who had multivessel PCI had a lower rate of reinfarction than those who had culprit-vessel-only PCI.

In patients with STEMI given crushed ticagrelor before PCI, using IV acetaminophen instead of IV fentanyl as a painkiller did not increase pain levels or platelet reactivity and prevented delay of ticagrelor’s effects, researchers reported.

In a retrospective study of patients with chronic total occlusion and multivessel CAD, CABG conferred better long-term outcomes than PCI, according to data presented at the virtual PCR e-Course.

BioFreedom stent (Biosensors) vs. Orsiro stent (Biotronik) in patients with atherosclerotic coronary artery lesions.

A novel ultrathin-strut biodegradable polymer sirolimus-eluting stent vs. a thin-strut permanent polymer everolimus-eluting stent.